News Results

There are 370,831 News Results

Jun 13, 2025
Revolutionizing Diagnostics: Digital Pathology Market Growth Report | Reach US$1.73 billion by 2030 at 8.0% CAGR | The Research Insights
CHICAGO, June 13, 2025 /PRNewswire/ --
Jun 24, 2025
REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe Atopic Dermatitis
Achieved statistical significance on primary endpoint at week 16 for mean percent change in EASI score from baseline for all rezpegaldesleukin arms versus placebo
Jul 14, 2025
Neurocrine Biosciences Presents One-Year Data Showing Sustained Efficacy of CRENESSITY® (crinecerfont) in Adult Patients, at ENDO 2025
-- One-year data from CAHtalyst((TM)) Adult study demonstrated lasting reductions in glucocorticoid dose and improvement in clinical outcomes in adults with classic congenital adrenal hyperplasia -- Results build upon previously...
Jul 14, 2025
Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst(TM) Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society's Annual Meeting
-- Adult and pediatric patients with classic congenital adrenal hyperplasia treated with CRENESSITY(®) (crinecerfont) achieved clinically meaningful weight reductions -- Substantial improvements in insulin resistance were also observed in both...
Jul 21, 2025
Managed Services Market to Reach USD 990,611.47 Million by 2032, Growing at a CAGR of 14.5%: Credence Research
PUNE, India, July 21, 2025 /PRNewswire/ -- The Managed Services Market is poised for substantial growth, with its value projected to increase from USD 335,320 million in 2024 to USD...
Jul 21, 2025
EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025
Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid- protofibrils in cerebrospinal fluid, and a subcutaneous form of lecanemab...
Jul 22, 2025
Danaher Reports Second Quarter 2025 Results
WASHINGTON, July 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 27, 2025.
Jul 24, 2025
Solaris Energy Infrastructure Announces Second Quarter 2025 Results, Updated Earnings Guidance and Continued Shareholder Returns
Solaris Energy Infrastructure, Inc. (NYSE:SEI) (“Solaris” or the “Company”), today announced second quarter 2025 financial and operational results and updated earnings guidance. Second Quarter 2025 Summary Results and Key Updates...
Jul 25, 2025
Lear Reports Second Quarter 2025 Results
SOUTHFIELD, Mich., July 25, 2025 /PRNewswire/ -- Lear Corporation (NYSE: LEA), a global automotive technology leader in Seating and E-Systems, today reported results for the second quarter 2025.
Jul 30, 2025
Nextracker Reports First Quarter Fiscal Year 2026 Financial Results
Nextracker (Nasdaq: NXT), a leading solar technology platform provider, today announced financial results for the first quarter of fiscal year 2026, ended June 27, 2025. Financial Summary (In millions, except...
37084

Pages

1

Stories of the day

Oct 3, 2025
Blighter Wins Contract from South East Asian Military for Smart and Scalable...
Oct 3, 2025
Denmark Deploys Terma’s Integrated Counter-UAS solution Across Strategic Sites
Oct 3, 2025
BAE Systems and Forterra join forces to develop autonomous Armored Multi-...
Oct 3, 2025
Oshkosh Defense Highlights U.S. Army Modernization with $89 Million PLS A2 Award